Because of the improved absorption that liposomal delivery offers, this lower dosage may be sufficient to deliver meaningful results compared to higher doses of standard supplements
Wound Healing & Tissue Regeneration By stimulating fibroblast proliferation and vascularization, GHK-Cu accelerates wound closure and scar remodeling
Whilst the market is currently led by Novo Nordisks semaglutide (Ozempic/Wegovy) and Eli Lillys tirzepatide (Mounjaro/Zepbound), stronger competition is expected with new entrants (Boehringer Ingelheim, Amgen, Pfizer, Roche amongst others) offering novel mechanisms (dual agonists, triple agonists and amylins), formulations (oral vs injectable) and dosing regimens (daily vs weekly vs monthly).
This resource is designed for PTs, ATCs, and rehabilitation providers who refer patients to Thrive for enhanced healing during their post-operative rehab process
They represent the formal regulatory position